|
Originally published In Press as doi:10.1074/jbc.M106996200 on October 31, 2001
J. Biol. Chem., Vol. 277, Issue 1, 303-309, January 4, 2002
Reelin Is a Serine Protease of the Extracellular Matrix*
Carlo C.
Quattrocchiabc,
Francesca
Wannenesde,
Antonio M.
Persicoa,
Silvia Anna
Ciafréd,
Gabriella
D'Arcangelofghi,
Maria G.
Faracef, and
Flavio
Kelleraj
From the a Laboratory of Neuroscience, Department of
Physiology and Neuroscience, Università "Campus Bio-Medico,"
Via Longoni 83, 00155 Roma, Italy, the b Program in
Neuroscience, Faculty of Medicine, University of Brescia, Via
Valsabbina 19, 25123 Brescia, Italy, the d Department of
Experimental Medicine and Biochemical Sciences, Università di Tor
Vergata, Via di Tor Vergata 135, 00133 Roma, Italy, the
e Department of Internal Medicine, Università di Tor
Vergata, Via di Tor Vergata 135, 00133 Roma, Italy, and f The
Cain Foundation Laboratories, g Department of Pediatrics,
h Program in Developmental Biology and i Division of
Neuroscience, Baylor College of Medicine, Houston, Texas 77030
Received for publication, July 24, 2001, and in revised form, October 18, 2001
 |
ABSTRACT |
Reelin is an extracellular matrix protein
that plays a pivotal role in development of the central nervous system.
Reelin is also expressed in the adult brain, notably in the cerebral
cortex, where it might play a role in synaptic plasticity. The
mechanism of action of reelin at the molecular level has been the
subject of several hypotheses. Here we show that reelin is a serine
protease and that proteolytic activity is relevant to its function,
since (i) Reelin expression in HEK 293T cells impairs their ability to
adhere to fibronectin-coated surfaces, and adhesion to fibronectin is
restored by micromolar concentrations of diisopropyl
phosphorofluoridate, a serine hydrolase inhibitor; (ii) purified Reelin
binds FP-Peg-biotin, a trap probe which irreversibly binds to serine
residues located in active catalytic sites of serine hydrolases; (iii)
purified Reelin rapidly degrades fibronectin and laminin, while
collagen IV is degraded at a much slower rate; fibronectin degradation is inhibited by inhibitors of serine proteases, and by monoclonal antibody CR-50, an antibody known to block the function of Reelin both
in vitro and in vivo. The proteolytic activity
of Reelin on adhesion molecules of the extracellular matrix and/or
receptors on neurons may explain how Reelin regulates neuronal
migration and synaptic plasticity.
 |
INTRODUCTION |
Reelin (1, 2) is an extracellular matrix protein that plays a
pivotal role in neuronal migration during development of laminar
structures of the mammalian brain including the cerebral cortex,
hippocampus, cerebellum, and several brainstem nuclei, as shown by
spontaneous Reelin null mutations (i.e. the
reeler mouse) (3, 4). In the developing cerebral cortex,
Reelin is secreted by Cajal-Retzius cells, located in the marginal
zone. Reelin must be secreted into the extracellular matrix to exert its biological effect (5).
In the reeler mouse, migrating neurons fail to pass through
earlier-generated neurons, possibly because they are unable to penetrate the subplate, or because they maintain extensive contacts with the radial glial fibers (6). Several hypotheses have been suggested regarding the function of Reelin: (i) Reelin may act as an
attractant molecule for migrating neurons; (ii) it may act as a
repulsive molecule; or (iii) Reelin may interrupt the association between migrating neurons and radial glia (7, 8), thus allowing migrating neurons to switch from a "gliophilic" to a
"neurophilic" state (9). Furthermore, Reelin has been recently
shown to be expressed in several adult neuronal cells, including
glutamatergic cerebellar granule neurons and specific GABAergic
interneurons of the cerebral cortex and hippocampus (10), and in the
adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells (11, 12). The cellular function of Reelin in the adult
organism is unknown. Evidence is accumulating for involvement of Reelin
in human diseases such as autosomal recessive lissencephaly (13),
schizophrenia (14), and autistic disorder (15).
The mouse Reelin sequence (1) encompasses 3461 amino acids and
possesses a signal peptide followed by a domain with 28% sequence
identity with F-spondin (as assessed by -Blast software), a protein secreted by floor plate cells and promoting cell adhesion and
neurite growth (16). This region is followed by a unique region with no
sequence homology, and then by eight internal repeats of 350-390 amino
acids, each repeat containing two related subdomains flanking a
cystein-rich sequence similar to the epidermal growth factor-like
motif. The carboxyl terminus region contains many positively charged
amino acids required for secretion (5). Human Reelin (2) is 94.8%
identical to the mouse protein at the amino acid level, indicating
strong functional conservation. Recent findings suggest that the Reelin
signal transduction involves binding to the very low density
lipoprotein receptor and to apoE receptor 2 followed by intracellular
activation of the adapter protein disabled-1 (17-19). Other possible
Reelin signal transduction pathways may involve interaction with the
3 1 integrin receptor (8, 9) and with
cadherin-related neuronal receptors (20).
We have analyzed the primary amino acid sequence of human Reelin, and
found several hints that Reelin might be a serine protease, since: (i)
Reelin contains the sequence GKSDG (amino acids 1280-1284 of human
Reelin) (2), corresponding to the serine hydrolase consensus sequence
GXSXG; this sequence is 100% conserved among mouse, chicken, and human Reelin; (ii) Reelin shows significant structural similarities with serine hydrolases, such as the
extracellular serine protease precursor (EC 3.4.21) of Serratia
marcescens, and the probable ubiquitin carboxyl-terminal
hydrolases FAM and FAF-Y (EC 3.1.2.15); (iii) Reelin contains eight
epidermal growth factor-like repeats; epidermal growth factor-like
repeats are observed in serine proteases, for example, coagulation
factors VII, IX, and X, and protein C, Z (21),
calcium-dependent serine proteinase (22) which degrades
extracellular matrix proteins, and complement C1s and C1r components
(23); (iv) several serine hydrolases, such as lipoprotein lipase and
the urokinase-type plasminogen activator, bind very low density
lipoprotein receptor and apoE receptor 2 (24, 25). In this study
we present converging evidence that purified Reelin acts as a serine
protease, and that this enzymatic activity may be relevant for its
cellular function.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
Cell culture media, antibiotics, and media
supplements were purchased from Invitrogen (Gaithersburg, MD). All
other chemicals were from Sigma, unless otherwise specified.
Amino acid Sequence Analysis of Reelin--
All sequence
analyses are based on human Reelin (accession number: NP005036) (2).
Homologies were evaluated by using -Blast 2 sequences software
(www.ncbi.nih.gov/blast). Also, PropSearch software (EMBL,
Heidelberg) was used to find homologies with other serine hydrolases.
PattinProt software (PBIL, NPSA, Lyon) was used to identify putative
consensus sequences for serine proteases.
Cell Culture, Transfection, and Expression of Recombinant
Reelin--
Human embryonic kidney (HEK) 293T cells (ATCC, Q401) were
grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, penicillin/streptomycin (100 international units/ml and 100 µg/ml, respectively), and 10 mM L-glutamine. All cells were cultured at
37 °C, 5% CO2 and 97% relative humidity. Passaging was
routinely performed with trypsin-EDTA. Cells were stably transfected
with 2 µg of plasmid DNA pCrl (5), which contains the entire mouse
Reelin open reading frame (accession number NP_035391), or with 2 µg
of pCDNA3 empty vector in 10 µl of LipofectAMINE in 4 ml of
Opti-MEM serum-free medium, according to the manufacturer's
instructions. Cells were transfected in 60-mm plates at a density of
5 × 105/dish and transferred to selection medium (0.6 mg/ml G418) 48 h after transfection. For Reelin purification, a
stable cell line (CER) was generated by stable transfection of 293-EBNA
cells (Invitrogen) with pCER followed by selection in medium containing
0.25 mg/ml G418 and 0.4 mg/ml hygromycin B. The pCER episomal plasmid
contains a reelin insert identical to that of pCrl, cloned
into the pCEP4 vector (Invitrogen).
Cultures were harvested for RNA preparation (26). Total RNA (3 µg)
was incubated in reaction buffer containing 5 µM random hexamer (Amersham Bioscience, Inc.), Moloney murine leukemia virus reverse transcriptase, reaction buffer, and RNase inhibitor, according to the manufacturer's specifications (Invitrogen). Reverse
transcription was performed for 1 h at 37 °C, and stopped by
incubating the samples for 10 min at 95 °C. Expression of Reelin was
checked by PCR amplification with specific primers: forward
5'-GGAAAGTCAGATGGAGAC-3', reverse 5'-CATCTAAGCCAAACG-3' corresponding
to nucleotides 4123-4498 of mouse Reelin mRNA (Ref. (1), accession
number U24703). PCR amplification was carried out in a total volume of
50 µl, with 10 µl of reverse transcription reaction and 1.25 units
of Taq polymerase (M-Medical Genenco-Life Science).
Amplification was performed for 35 cycles (1 min denaturing at
94 °C, 1 min annealing at 58 °C, and 1 min extension at 72 °C)
in a thermal cycler (Oracle BioSystems, Delphi 1500). The 376-bp
amplified product was analyzed by 2% agarose gel electrophoresis and
visualized under UV illumination after staining with ethidium bromide.
Reelin secretion into supernatants was analyzed by plating 1 × 106 cells onto 90-mm dishes. After 24 h conditioned
media were removed, cells were washed twice with phosphate-buffered
saline (PBS), and serum-free Dulbecco's modified Eagle's medium was
added. Forty-eight hours later, the supernatants were collected,
cleared by a brief centrifugation (10 min, 1000 rpm) at 4 °C,
concentrated by Microcon YM-100 (Millipore Corp. Bedford, MA) and
stored at 80 °C for analysis by SDS-PAGE and immunoblotting.
Reelin secretion into the cell culture medium was assessed by Western
blots using mAb 142, an antibody that recognizes the
NH2-terminal sequence of Reelin (27).
Cell Adhesion Assay--
Cell adhesion assay was performed
according to published protocols (28). Ninety-six-well plates were
coated overnight with fibronectin (2.5 µg/ml) in
carbonate/bicarbonate buffer, pH 9.7. Cells were harvested, washed
three times with serum-free Dulbecco's modified Eagle's medium, and
then resuspended in sterile attachment solution (calcium- and
magnesium-free Hanks' balanced salt solution, 20 mM HEPES,
1 mg/ml heat-inactivated bovine serum albumin, 1 mM
CaCl2, 1 mM MgCl2. Mock- and
pCrl-transfected 293T cells (1 × 104 in 200 µl/well) were allowed to attach for 2 h at 37 °C in a humidified 5% CO2 incubator. Unattached cells were removed
with Hanks' balanced salt solution. Attached cells were fixed with 4%
formaldehyde in PBS, pH 7.4, and counted manually using an inverted
microscope by two different observers. The counting area was defined by
a grid (12 mm2 area) placed under the wells. Attached cells
were defined as cells that had spread and grown at least 1 process. All
data are expressed as mean ± S.E. Differences between groups were
tested by one-way ANOVA followed by the LSD post-hoc test, using the SPSS statistics package (SPSS, Chicago, IL, version 9.0).
Gel Electrophoresis and Immunoblotting--
Samples were mixed
with 2 × sample buffer and heated at 100 °C for 2 min. Six
percent resolving gel, pH 8.8, and 5% stacking gel, pH 6.8, were
prepared and run in a MiniProtean II assembly (Bio-Rad, Hercules, CA)
according to standard protocols (29). Proteins were transferred to
nitrocellulose filter (Schleicher & Schuell, GmbH, Dassel, Germany) by
a semi-dry blotting apparatus (Hoefer Scientific, Amersham Bioscience,
Inc., San Francisco, CA) for 90 min at constant current of 70 mA. After
blotting, the nitrocellulose filter was blocked for 30 min in
tris-buffered saline with 0.1% Tween 20 (TBST), containing 1% bovine
serum albumin. Reelin was revealed with 1:2000 mAb 142, overnight,
followed by 1:5000 alkaline phosphatase-labeled anti-mouse IgG (Promega
Italia, Milan, Italy). Filters were developed with nitro blue
tetrazolium-5-bromo-4-chloro-3-indolyl phosphate in Tris-HCl, pH 9.5, containing 5 mM MgCl2. The reaction was stopped
with PBS containing 2 mM EDTA. Alternatively, Reelin bands
were revealed using a chemiluminescence method: filters were
incubated with biotinylated anti-mouse secondary antibody (1:25.000 in
TBST) for 1 h. Then, after three washes, 1:500
peroxidase-conjugated streptavidin (CHEMICON Int., Temecula, CA) was
added for 15 min. Finally filters was washed, incubated in a freshly
made solution containing 200 mM Tris-HCl, pH 8.5, 250 mM 3-aminophthalhydrazide, 40 mM
p-coumaric acid, and 0.0005%
H2O2, dried, and exposed to Kodak X-OMAT film.
Filters or films were scanned with a SCANJET ADF digital scanner using
Twain-32 software (Hewlett-Packard). The specificity of staining was
checked by preincubating mAb 142 with protein SP, the Reelin fragment
recognized by mAb 142 (27).
Labeling of Reelin with FP-Peg-biotin--
Fluorophosphate
biotin (FP-Peg-biotin) (a gift of Dr. Benjamin Cravatt) (30), stored as
a 100 mM stock solution in Me2SO at 20 °C,
was added directly to protein samples to a final concentration of 2-4
µM. The reaction mixture was incubated at room
temperature for 30 min, and stopped by adding an equal volume of 2 × reducing sample buffer. As a control for the specificity of
FP-Peg-biotin labeling, replica samples were incubated for 1 h
with 11.4 µM diisopropylphosphofluoridate
(DFP),1 a potent and specific
serine-hydrolase inhibitor, before incubation with FP-Peg-biotin.
Samples were separated by SDS-PAGE and transferred by electroblotting
to nitrocellulose membranes; the membranes were blocked in TBST with
3% bovine serum albumin for 1 h at 25 °C or overnight at
4 °C, and then incubated for 15 min with an avidin-horseradish
peroxidase conjugate (Pierce) diluted 1:300 in blocking solution. The
labeled bands were revealed by chemiluminescence (see above).
Purification of Reelin--
For gel filtration chromatography
purification, 50 µl of supernatant from Reelin secreting
CER cells were concentrated first by osmotic dyalisis with AQUACIDE I
(Calbiochem, La Jolla, CA). A 5-ml concentrated sample was loaded on a
FPLC system ÄKTAprime and passed through a HiLoad Superdex 200 26/60 column (Amersham Bioscience, Inc., Uppsala, Sweden). The run was
performed at a constant flow rate of 3 ml/min and maximal pressure
limit of 0.5 Pa. The eluate was collected in 1.5-ml fractions. After
dot immunoblot screening and Western blot, positive fractions for
Reelin were pooled and concentrated again as described above.
For purification by SDS-PAGE, Reelin-containing supernatant from
transfected 293T cells was concentrated as above and separated on a 5%
gel. The gel was run for 3 h 30 min at 125 V to achieve a good
separation in the >250 kDa range. Thereafter a thin vertical slice of
gel was cut and stained with silver to reveal the 400-kDa Reelin band.
A 5-mm wide horizontal slice was cut from the remaining gel, using the
stained slice as a reference, and 400-kDa Reelin was electroeluted at
60 V into 25 mM Tris, 250 mM glycine, 0,1% SDS
buffer. Electroelution was carried out overnight at 4 °C. Purified
Reelin was, then, transferred to PBS, pH 7.2, by overnight dialysis in
a Slide-A-Lyzer cassette (Pierce). Finally the protein was
concentrated. The final protein concentration was estimated to be 0.2 µg/ml (Bradford Reagent, Sigma). Purified Reelin was re-electrophoresed on a SDS gel to check the purity of the protein.
Degradation of Extracellular Matrix Proteins--
Reelin
aliquots (10 ng) were incubated with 1 µg of fibronectin from human
plasma (Sigma), or with laminin or collagen type IV from basement
membrane of Engelbreth-Holm-Swarm mouse sarcoma (Sigma) for 0, 10, 30, or 120 min at 37 °C, in PBS, pH 7.9. The reaction was stopped by
adding sample buffer and heating the samples at 100 °C for 2 min.
Samples were separated in a 8% SDS gel. After electrophoresis, the gel
was fixed, and silver-stained.
 |
RESULTS |
Reelin Contains Regions of Homology with Serine
Proteases--
Human Reelin contains the sequence GKSDG (amino acids
1280-1284), homologous to the consensus sequence
GXSXG of serine proteases (Fig.
1). Furthermore, searches of the Reelin
sequence for consensus patterns (PROSITE
www.ich/ucl.ac.uk/cmgs/serpro.htm) around hypothetical amino acids of
the catalytic triad (Ser, His, and Asp) using PattinProt (PBIL, NPSA,
Lyon), yielded several sequences sharing >60% homology with serine
proteases (Fig. 1).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Consensus sequence analysis of Reelin around
hypothetically catalytic amino acids (serine, histidine, and aspartic
acid) of serine proteases. Identical or homologous residues are
shaded.
|
|
Reelin Inhibits Cell Attachment in Vitro--
To obtain
recombinant Reelin protein, HEK 293T cells were transfected with pCrl
plasmid, and Reelin mRNA expression was assessed by RT-PCR, using
primers complementary to exon 27 sequences. RT-PCR of pCrl-transfected
cells revealed the expected 376-bp band (Fig. 2A, lane 3), while
the band was absent in mock-transfected cells (lane 2).
Reelin secretion into the supernatant was confirmed by Western
blotting. The supernatant of pCrl-transfected cells showed a major
Reelin band at approximately 400 kDa, and minor bands at 350 and 140 kDa (Fig. 2B, lane 2). The supernatant of mock-transfected cells did not show any stained bands (lane
1).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
HEK 293T cells transfected with the pCrl
vector express Reelin mRNA and secrete Reelin in the
supernatant. A, total RNA was extracted from cell
homogenates and pCrl mRNA expression was probed with RT-PCR, using
primers corresponding to exon 27 of Reelin. Lanes 1, PCR of
pCrl vector; 2, RT-PCR of
mock-(pCDNA3)-transfected cells; 3, RT-PCR of
pCrl-transfected cells. The position of the 350-bp marker is indicated
on the left. B, Western blot of cell culture
supernatants, probed with anti-Reelin mAb 142. Lanes 1,
supernatant from mock-transfected cells; 2, supernatant from
pCrl-transfected cells; 1' and 2' replica samples of lanes 1 and 2, after silver stain. The position of 250- and 150-kDa
markers is indicated.
|
|
HEK 293T cells endogenously express 5 1
integrin which specifically mediates adhesion to fibronectin (28).
Titration experiments showed dose-dependent adhesion to
fibronectin, with maximal adhesion occurring at 2.5-5 µg/ml
fibronectin (data not shown). Reelin-transfected HEK 293T showed
significantly less adhesion as compared with mock-transfected HEK 293T
cells. After a 2-h incubation, 44.7 ± 6.3 (mean ± S.E.) pCrl-transfected cells were attached to the substrate, as compared with
96.3 ± 10.8 mock-transfected cells (Fig.
3A, p < 0.001). Furthermore, cell morphology was markedly different:
Reelin-secreting cells appeared unable to spread on fibronectin and
their processes were diminished in number and length, as compared with
mock-transfected cells (Fig. 3B). To assess the biological
significance of the enzymatic activity of Reelin, the effect of DFP, a
potent and specific inhibitor of serine hydrolases, on cell adhesion
was studied. Micromolar concentrations of DFP partially restored
adhesion of Reelin-expressing cells on fibronectin, without affecting
mock-transfected cells (Fig. 3, A and B). The
effect of DFP was dose-dependent, starting at
concentrations 0.54 µM; maximal increase in adhesion of
Reelin-expressing cells was seen at 5.4 µM DFP, while 5.4 mM was equally toxic for pCrl- and mock-transfected cells,
inhibiting adhesion of >99% of the cells (Fig. 3C).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of Reelin inhibits adhesion of HEK
293T cells to fibronectin, and DFP treatment reverses the effect of
Reelin expression. A, quantification of the effect of
various treatments. Bars show the numbers of cells attached
to fibronectin-coated wells under different conditions. Each
bar represent the mean and S.E. of five wells.
Double-headed arrows indicate the statistical difference
between groups (one-way ANOVA followed by LSD post-hoc test).
B, phase-contrast images of cells grown in different
conditions. DFP was applied at a concentration of 5.4 µM.
C, dose-dependent effect of DFP on cell adhesion
of mock- or pCrl-transfected HEK 293T cells. Each point represents the
percent ratio between the number of attached cells after DFP treatment
and the number of attached cells in the absence of DFP.
|
|
Reelin Binds a Serine Hydrolase Probe--
FP-Peg-biotin is
described to behave as a specific and irreversible probe for serine
hydrolases, showing properties similar to those of common FP
inhibitors, such as DFP (30). To explore Reelin labeling with
FP-Peg-biotin, aliquots of transfected 293T cell culture supernatants
incubated with 5 µM FP-Peg-biotin were separated on
standard SDS-PAGE gels, blotted, and probed with avidin peroxidase;
replica samples were stained with the monoclonal antibody 142. The
supernatant of Reelin-expressing cells showed distinct Reelin bands at
approximately 400, 300, and 140 kDa (Fig. 4A, lane 2). The
400- and 300-kDa band showed faint labeling with FP-Peg-biotin, while
the 140-kDa band showed strong labeling with FP-Peg-biotin (Fig.
4B, lane 1; arrows indicate
corresponding bands in the two blots). Labeling of these three bands
was inhibited by DFP (Fig. 4B, lane 2). The
supernatant of mock-transfected cells showed a completely different
labeling pattern with FP-Peg-biotin: the most evidently labeled band
was a 150-kDa band, while no labeled bands were visible at 400 and 140 kDa (Fig. 4B, lane 3). Given the complex pattern
of labeling with FP-Peg-biotin in supernatants, we decided to perform
FP-Peg-biotin labeling on partially purified Reelin. The supernatant of
the stable cell line CER, expressing high levels of Reelin, was
concentrated and partially purified by gel filtration chromatography.
The Reelin-positive eluate from the Superdex 200 gel filtration column
was concentrated and then incubated in the absence or presence of the
serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF). The
samples were separated by SDS-PAGE on a 4-12% gradient gel, blotted,
and incubated with the monoclonal antibody E4 to reveal Reelin (Fig.
5A, lanes 1 and
2). The blot was then stripped and incubated with
streptavidin to reveal the binding to FP-Peg-biotin (Fig.
5A, lanes 3 and 4). As with the crude
supernatant (Figs. 2 and 4), the immunoblot showed two major
Reelin-positive bands, one higher than the 250-kDa marker,
corresponding to the 400- and 300-kDa isoforms, and a smaller band at
about 140 kDa (Fig. 5A, lanes 1 and
2). FP-Peg-biotin binds to both major Reelin bands in the
absence, but not in the presence of PMSF (Fig. 5A,
lanes 3 and 4). The smaller band appeared to bind
FP-Peg-biotin with a higher affinity than the higher molecular weight
isoform (Fig. 5A, lane 3).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 4.
Reelin can be labeled with FP-Peg-biotin, a
serine trap probe, and labeling is inhibited by DFP. A,
aliquots of supernatants were separated by SDS-PAGE, blotted, and
stained with mAb 142. Lanes 1, Mock-transfected HEK 293T
cells; 2, pCrl-transfected cells; arrows indicate
Reelin bands. B, FP-Peg-biotin labels several bands in the
supernatants. Lanes 1, supernatant of pCrl-transfected
cells; arrows indicate bands corresponding to the 400-, 300-, and 140-kDa Reelin bands; 2, replica sample as in
lane 1, but preincubated with 11 µM DFP;
3, supernatant of mock-transfected cells; 4,
replica sample as in lane 3, but preincubated in the
presence of 11 µM DFP. Two-hundred and fifty ng of total
protein were applied to each lane.
|
|

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 5.
Purification of Reelin by fast protein liquid
chromatography and SDS-PAGE electroelution, and labeling of purified
Reelin with FP-Peg-biotin. A, the concentrated
supernatant from CER cells was purified on a Sephadex-200 gel
filtration column; the Reelin-positive eluate from the column was
separated on a 4-12% gradient SDS-PAGE. Lanes 1 and
2, immunoblot (mAb E4) of the sample incubated with
FP-Peg-biotin after pretreatment without and with PMSF, respectively.
Lanes 3 and 4, the blot was stripped and
developed with horseradish peroxidase-conjugated streptavidin to reveal
bound FP-Peg-biotin. The 250-kDa calibration marker shown next to
lane 1 is valid for all 4 lanes. B, supernatants
of mock-transfected (lane 1) and pCrl-transfected cells
(lane 2) were separated with SDS-PAGE (5% gel) for 3 h
30 min and the gel was stained with silver nitrate. The
arrow next to lane 2 indicates the 400-kDa Reelin
band. Lanes 3 and 4, blot corresponding to
lanes 1 and 2, respectively, stained with
anti-Reelin mAb 142. The arrow next to lane 4 points to 400-kDa Reelin. The 250-kDa calibration marker next to
lane 1 is valid for lanes 2-4 as well.
Lane 5, the 400-kDa Reelin band shown in lane 2 was electroeluted, electrophoresed in a second gel, blotted, and
stained with mAb 142. The asterisks mark degradation
products of Reelin at approximately 180 and 140 kDa. The 400-kDa band
has practically disappeared.
|
|
Reelin Shows Protease Activity on Extracellular Matrix Proteins in
Vitro--
To investigate the catalytic activity of Reelin, we first
further purified the high molecular weight isoforms by SDS-PAGE and
electroelution. As shown in Fig. 5B, separation of the
concentrated cell culture supernatant using a 5% SDS gel resulted in a
good separation of the Reelin isoforms. Silver nitrate staining
indicated that only the supernatant of Reelin expressing cells contains a band at approximately 400 kDa corresponding to the Reelin isoforms of
400 (and 300) kDa (Fig. 5B, lanes 2 and
4). Therefore, the high molecular weight Reelin band was
electroeluted from the gel to achieve a high degree of purification.
The electroeluted sample was reanalyzed by SDS-PAGE and Western
blotting (Fig. 5B, lane 5). However, we found
that the purified high molecular weight Reelin protein quickly
disappeared and smaller bands appeared around 180 and 140 kDa, probably
corresponding to self-degradation products. The major proteolytic
product of 140 kDa that we observed in this study may correspond to the
180-kDa degradation product that has been described by other
investigators (8, 35).
To test for proteolytic activity on extracellular matrix proteins,
purified Reelin was incubated with pure fibronectin, laminin, or
collagen IV, and breakdown products were analyzed by SDS-PAGE and
silver staining of gels. Fibronectin and laminin breakdown fragments
were seen already after 10 min incubation (Fig.
6, A and D), while
collagen IV was degraded at a much slower rate (Fig. 6E).
Fibronectin degradation was blocked by inhibitors of serine proteases
(DFP, PMSF, and aprotinin), but not by inhibitors of other families of
proteases (Fig. 6B). Fibronectin degradation was also
partially inhibited by monoclonal antibody CR-50 (Fig. 6C),
an antibody directed against the NH2-terminal portion of Reelin that has been demonstrated to inhibit Reelin function both in vitro and in vivo (see Ref. 31 and references
quoted therein). Inhibition of fibronectin degradation was seen at a
CR-50 concentration of 9.8 µg/ml, the highest concentration tested.
Interestingly, this concentration is comparable with the concentrations
that have been reported in the literature to inhibit Reelin function (20-200 µg/ml, Ref. 31).

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 6.
Purified Reelin rapidly degrades ECM proteins
fibronectin and laminin, while collagen IV is degraded at a much slower
rate. Protein degradation was assessed with SDS-PAGE and silver
staining of gels. A, time course of fibronectin degradation
by Reelin; human fibronectin (1 µg) was incubated with purified
Reelin (5 ng) for 0, 10, 30, and 120 min at 37 °C. C: intact
fibronectin. B, degradation of fibronectin by Reelin is
inhibited by serine protease inhibitors, but not by inhibitors of other
classes of proteases; fibronectin was incubated with Reelin for 120 min
at 37 °C in the presence of different protease inhibitors; control,
intact fibronectin; concentrations of inhibitors are: DFP, 21.6 mM; PMSF, 2 mg/ml; aprotinin, 1 mg/ml; leupeptin, 1 mg/ml;
pepstatin, 0.1 mg/ml; EDTA, 10 mM. C,
degradation of fibronectin by Reelin is partially inhibited by mAb
CR-50. Lane 1, purified CR-50, arrows point to
the heavy and light chains of the antibody. Lanes 2-4,
fibronectin incubated with Reelin for 120 min at 37 °C in the
absence (lane 2) or presence (lanes 3 and 4) of
mAb CR-50 (lane 3, 0.098 µg/ml; lane 4, 9.8 µg/ml). Arrow next to lane 4 points to intact
fibronectin. D, degradation of laminin by Reelin;
C, laminin alone. E, degradation of collagen IV
by Reelin; C, collagen IV alone. The positions of molecular
weight markers are indicated on the left of the gels.
Molecular weight markers indicated in A are also for
B and C.
|
|
 |
DISCUSSION |
In this paper we present converging biochemical and cellular
evidence that Reelin is a serine protease of the extracellular matrix,
and that its enzymatic activity is important for the modulation of cell
adhesion. The fact that CR-50, a monoclonal antibody known to inhibit
Reelin function both in vitro and in vivo, blocks
the proteolytic activity of Reelin further supports the hypothesis that
proteolytic activity is of fundamental importance for the function of
Reelin. These findings appear interesting in view of the fact that
serine proteases, such as tissue plasminogen activator (tPA), are
already known to be important modulators of cell migration and axon
growth (32).
HEK 293T cells adhere quickly to fibronectin, due to endogenous
expression of 5 1 integrin (28), which is
a selective fibronectin receptor (33). In this paper we show that
expression of Reelin leads to a marked decrease of adhesion of HEK 293T
cells to fibronectin. These data, together with the demonstration that
purified Reelin degrades fibronectin in vitro, are
consistent with the hypothesis that Reelin, secreted by HEK 293T cells,
inhibits cell adhesion by degrading the fibronectin substrate.
Alternatively, Reelin might activate other targets, for example, cell
membrane receptors or other proteases, which are in turn directly
responsible for cell detachment. A third hypothesis is that Reelin
induces the expression of another serine protease, which is in turn
responsible for cell detachment. This hypothesis appears remote, since
we have demonstrated that Reelin binds FP-Peg-biotin, and degrades fibronectin in vitro.
We found that, after purification, Reelin appears to undergo rapid
self-degradation. Our data suggest that the major 140-kDa fragment is
enzymatically active, since its binding to FP-Peg-biotin is even
stronger than that of full-length Reelin. Interestingly, we also
observed strong labeling with FP-Peg-biotin of the smaller fragment
after immunoaffinity purification of Reelin from mouse brain.2 These data support
the idea that the proteolytic processing of Reelin is functionally
important, and that full activity of Reelin might require degradation
of the 400-kDa full-length precursor to generate smaller, more active isoforms.
Reelin appears to behave as a specific serine protease, as collagen IV
is degraded at a much slower rate than fibronectin or laminin. However,
this hypothesis needs further confirmation, using model peptide substrates.
Reelin has been suggested to allow migrating neurons to grow past
previously migrated cells and to promote detachment of neurons from
radial glial fibers (6-8). The 5 integrin subunit,
expressed in HEK 293T cells, shows high homology with the
3 subunit, which is expressed on migrating neurons, and
appears to be involved in the inhibitory effect of Reelin on neuronal
migration along radial glial processes. Reelin has been demonstrated to
bind to 3 1 integrin (8). In
situ hybridization experiments and double immunolabeling with
antibodies against fibronectin and antibodies against radial glia
demonstrate transient fibronectin expression on radial glia processes
during early stages of cortical development, until completion of
corticogenesis (34). On the basis of the available evidence, we propose
that 3 1 integrin might immobilize extracellular Reelin on the surface of migrating neurons and thus focus
its proteolytic activity on fibronectin expressed on radial glial
cells. Alternatively, binding to 3 1
integrin might enhance the activity of Reelin by protecting it from
degradation. In this respect it is interesting to notice that elevated
levels of cleaved Reelin have been detected in the absence of
3 1 integrin. This finding has been
interpreted as evidence that 3 1
integrin inhibits degradation of Reelin by modulating the
activity of a zinc-dependent metalloproteinase (8, 35). Our
data are consistent with the simpler hypothesis that the appearance of
Reelin fragments is the result of a self-degradation activity, and that
3 1 integrin might protect Reelin from
self-degradation.
Our data are consistent with a role for integrins in Reelin-mediated
cell adhesion. However, the action of Reelin on neuronal migration may
be mediated by other pathways, such as the very low density lipoprotein
receptor/apoE receptor 2/disabled-1 pathway (17-19). It is
conceivable, for example, that Reelin may cleave these lipoprotein
receptors and thereby activate the disabled-1 signaling pathway.
Furthermore, in our cell culture model the action of Reelin is
incompletely blocked by DFP, indicating that Reelin might also act via
pathways that are independent of serine protease activity. Finally, it
should be noted that 5 1, the integrin
expressed by HEK 293T cells, is a highly selective receptor for
fibronectin (33). Thus, HEK 293T cells might be much more sensitive to
integrin-fibronectin interactions than cortical neurons in the
developing brain, where other cell adhesion complexes might be predominant.
The discovery of Reelin's function as a serine protease of the
extracellular matrix is also intriguing when considering the expression
and distribution of Reelin and adhesion molecules of the extracellular
matrix in structures other than the developing cerebral cortex. Reelin
is co-expressed with integrins in dendritic spines of GABAergic neurons
in the adult cerebral cortex, and of glutamatergic neurons in the
cerebellum and olfactory bulb (10, 11, 36). Dendritic spine density is
decreased in fronto-parietal cortex and CA1 pyramidal neurons of
heterozygous reeler mice (37), and heterozygous
reeler mice show abnormalities in complex behavior, like
neophobia and increased anxiety (38), a finding that led investigators
to propose these mice as an animal model of schizophrenia. We suggest
that the synaptic role of Reelin as a serine protease might consist in
a rapid and local modulation of adhesive forces between pre- and
post-synaptic elements, thus modulating the efficiency of synaptic
transmission at the local level. In fact, other serine proteases, like
tPA and plasmin, have already been suspected to be involved in synaptic
plasticity. tPA contributes to the late phase of long-term potentiation
in hippocampal slices and stimulates synapse formation in hippocampal
cell culture (39). Plasmin cleaves laminin and appears to regulate
long-term potentiation (40). In conclusion, our findings may help to
better understand the roles of Reelin both in physiology and in
disease, by bringing this protein into the complex and exciting
scenario of protease-regulated signaling networks.
 |
ACKNOWLEDGEMENTS |
We are deeply grateful to Dr. A. M. Goffinet for the gift of monoclonal antibodies 142 and G10 and Dr.
Benjamin Cravatt for the gift of FP-Peg-biotin. Furthermore, we
thank Graziano Bonelli, Marco De Luca, and Ramona Marino for technical
assistance, and Flavia Mancuso for editorial assistance.
 |
FOOTNOTES |
*
This work was supported by Consiglio Nazionale delle
Ricerche Programma "Biomolecole per la salute umana" Grant
99.00555.PF33.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
c
Present address: Dept. of Pediatrics-Neurology, Baylor
College of Medicine, 1102 Bates St., MC 3-6365, Houston, TX 77030.
j
To whom correspondence should be addressed: Laboratory of
Neuroscience, Università "Campus Bio-Medico," Via Longoni 83, 00155 Roma, Italy. Tel.: 39-06-2254-1335; Fax: 39-06-22-54-14-56;
E-mail: f.keller@unicampus.it.
Published, JBC Papers in Press, October 31, 2001, DOI 10.1074/jbc.M106996200
2
C. C. Quattrocchi and F. Keller,
unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
DFP, diisopropylphosphorofluoridate;
HEK, human embryonic kidney;
mAb, monoclonal antibody;
PBS, phosphate-buffered saline;
PMSF, phenylmethylsulfonyl fluoride;
tPA, tissue plasminogen activator.
 |
REFERENCES |
| 1.
|
D`Arcangelo, G.,
Miao, G. G.,
Chen, S.,
Soares, H. D.,
Morgan, J. I.,
and Curran, T.
(1995)
Nature
374,
719-723[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
De Silva, U.,
D'Arcangelo, G.,
Braden, V. V.,
Chen, J.,
Miao, G. G.,
Curran, T.,
and Green, E. D.
(1997)
Genome Res.
7,
157-164[Abstract/Free Full Text]
|
| 3.
|
Goffinet, A. M.
(1984)
Brain Res. Brain Res. Rev.
7,
261-296[CrossRef]
|
| 4.
|
Alcantara, S.,
Ruiz, M.,
D'Arcangelo, G.,
Ezan, F.,
de Lecea, L.,
Curran, T.,
Stelo, C.,
and Soriano, E.
(1998)
J. Neurosci.
18,
7779-7799[Abstract/Free Full Text]
|
| 5.
|
D'Arcangelo, G.,
Nakajima, K.,
Miyata, T.,
Ogawa, M.,
Mikoshiba, K.,
and Curran, T.
(1997)
J. Neurosci.
17,
23-31[Abstract/Free Full Text]
|
| 6.
|
Pinto-Lord, M. C.,
Evrard, P.,
and Caviness, V. S.
(1982)
Brain Res.
256,
379-393[Medline]
[Order article via Infotrieve]
|
| 7.
|
Hoffarth, R. M.,
Johnston, J. G.,
Krushel, L. A.,
and van der Kooy, D.
(1995)
J. Neurosci.
15,
4838-4850[Abstract]
|
| 8.
|
Dulabon, L.,
Olson, E. C.,
Taglienti, M. G.,
Eisenhuth, S.,
McGrath, B.,
Walsh, C. A.,
Kreidberg, J. A.,
and Anton, E. S.
(2000)
Neuron
27,
33-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Anton, E. S.,
Kreidberg, J. A.,
and Rakic, P.
(1999)
Neuron
22,
277-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Pesold, C.,
Liu, W. S.,
Guidotti, A.,
Costa, E.,
and Caruncho, H. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3217-3222[Abstract/Free Full Text]
|
| 11.
|
Pesold, C.,
Impagnatiello, F.,
Pisu, M. G.,
Uzunov, D. P.,
Costa, E.,
Guidotti, A.,
and Caruncho, H. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3221-3226[Abstract/Free Full Text]
|
| 12.
|
Smalheiser, N. R.,
Costa, E.,
Guidotti, A.,
Impagnatiello, F.,
Auta, J.,
Lacor, P.,
Kriho, V.,
and Pappas, G. D.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1281-1286[Abstract/Free Full Text]
|
| 13.
|
Hong, S. E.,
Shugart, Y. Y.,
Huang, D. T.,
Shahwan, S.,
Grant, P. E.,
Hourihane, J. O. B.,
Martin, N. D. T.,
and Walsh, C. A.
(2000)
Nat. Genet.
26,
93-96[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Guidotti, A.,
Auta, J.,
Davis, J. M.,
Gerevini, V. D.,
Dwivedi, Y.,
Grayson, D. R.,
Impagnatiello, F.,
Pandey, G.,
Pesold, C.,
Sharma, R.,
Uzunov, D.,
and Costa, E.
(2000)
Arch. Gen. Psychiatry
57,
1061-1069[Abstract/Free Full Text]
|
| 15.
|
Persico, A. M.,
D'Agruma, L.,
Maiorano, N.,
Totaro, A.,
Militerni, R.,
Bravaccio, C.,
Wassink, T. H.,
Schneider, C.,
Melmed, R.,
Trillo, S.,
Montecchi, F.,
Palermo, M.,
Pascucci, T.,
Puglisi-Allegra, S.,
Reichelt, K. L.,
Conciatori, M.,
Marino, R.,
Quattrocchi, C. C.,
Baldi, A.,
Zelante, L.,
Gasparini, P.,
and Keller, F.
(2001)
Mol. Psychiatry
6,
150-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Klar, A.,
Baldassare, M.,
and Jessell, T. M.
(1992)
Cell
69,
95-110[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Hiesberger, T.,
Trommsdorff, M.,
Howell, B. W.,
Goffinet, A.,
Mumby, M. C.,
Cooper, J. A.,
and Herz, J.
(1999)
Neuron
24,
481-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
D'Arcangelo, G.,
Homayouni, R.,
Keshvara, L.,
Rice, D. S.,
Sheldon, M.,
and Curran, T.
(1999)
Neuron
24,
471-479[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Trommsdorff, M.,
Gotthardt, M.,
Hiesberger, T.,
Shelton, J.,
Stockinger, W.,
Nimpf, J.,
Hammer, R. E.,
Richardson, J. A.,
and Herz, J.
(1999)
Cell
97,
689-701[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Senzaki, K.,
Ogawa, M.,
and Yagi, T.
(1999)
Cell
99,
635-647[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kalafatis, M.,
Egan, J. O.,
van't Veer, C.,
Cawther, K. M.,
and Mann, K. G.
(1997)
Crit. Rev. Eukaryotic Gene Expr.
7,
241-280[Medline]
[Order article via Infotrieve]
|
| 22.
|
Kinoshita, H.,
Sakiyama, H.,
Tokunaga, K.,
Imajoh-Ohmi, S.,
Hamada, Y.,
Isono, K.,
and Sakiyama, S.
(1989)
FEBS Lett.
250,
411-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kusumoto, H.,
Hirosawa, S.,
Salier, J. P.,
Hagen, F. S.,
and Kurachi, K.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
7307-7311[Abstract/Free Full Text]
|
| 24.
|
Cooper, J. A.,
and Howell, B. W.
(1999)
Cell
97,
671-674[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Gliemann, J.
(1998)
Biol. Chem.
379,
951-964[Medline]
[Order article via Infotrieve]
|
| 26.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
|
| 27.
|
de Bergeyck, V.,
Naerhuyzen, B.,
Goffinet, A. M.,
and Lambert de Rouvroit, C.
(1998)
J. Neurosci. Methods
82,
17-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Abraham, D. G.,
Nutt, E. M.,
Bednar, R. A.,
Bednar, B.,
Gould, R. J.,
and Duong, Le T.
(1997)
Mol. Pharmacol.
52,
227-236[Abstract/Free Full Text]
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Liu, Y.,
Patricelli, M. P.,
and Cravatt, B. F.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14694-14699[Abstract/Free Full Text]
|
| 31.
|
Utsunomiya-Tate, N.,
Kubo, K.,
Tate, S.,
Kainosho, M.,
Katayama, E.,
Nakajima, K.,
and Mikoshiba, K.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
9729-9734[Abstract/Free Full Text]
|
| 32.
|
Seeds, N. W.,
Basham, M. E.,
and Haffke, S. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14118-14123[Abstract/Free Full Text]
|
| 33.
|
Miyamoto, S.,
Katz, B. Z.,
Lafrenie, R. M.,
and Yamada, K. M.
(1998)
Ann. N. Y. Acad. Sci.
857,
119-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Sheppard, A. M.,
Hamilton, S. K.,
and Pearlman, A. L.
(1991)
J. Neurosci.
11,
3928-3942[Abstract]
|
| 35.
|
Lambert de Rouvroit, C.,
de Bergeyck, V.,
Cortvrindt, C.,
Bar, I.,
Eeckhout, Y.,
and Goffinet, A. M.
(1999)
Exp. Neurol.
156,
214-217[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Rodriguez, M. A.,
Pesold, C.,
Liu, W. S.,
Kriho, V.,
Guidotti, A.,
Pappas, G. D.,
and Costa, E.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3550-3555[Abstract/Free Full Text]
|
| 37.
|
Liu, W. S.,
Pesold, C.,
Rodriguez, M. A.,
Carboni, G.,
Auta, J.,
Lacor, P.,
Larson, J.,
Condie, B. G.,
Guidotti, A.,
and Costa, E.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
3477-3482[Abstract/Free Full Text]
|
| 38.
|
Tueting, P.,
Costa, E.,
Dwivedi, Y.,
Guidotti, A.,
Impagnatiello, F.,
Manev, R.,
and Pesold, C.
(1999)
Neuroreport
10,
1329-1334[Medline]
[Order article via Infotrieve]
|
| 39.
|
Baranes, D.,
Lederfein, D.,
Huang, Y.,
Chen, M.,
Bailey, C. H.,
and Kandel, E.
(1998)
Neuron
21,
813-825[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Nakagami, Y.,
Abe, K.,
Nishiyama, N.,
and Matsuki, N.
(2000)
J. Neurosci.
20,
2003-2010[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I Richard
The genetic and molecular bases of monogenic disorders affecting proteolytic systems
J. Med. Genet.,
July 1, 2005;
42(7):
529 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Kim, R. Koyama, R. X. Yamada, M. K. Yamada, N. Nishiyama, N. Matsuki, and Y. Ikegaya
Environmental Control of the Survival and Differentiation of Dentate Granule Neurons
Cereb Cortex,
December 1, 2004;
14(12):
1358 - 1364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Erbel-Sieler, C. Dudley, Y. Zhou, X. Wu, S. J. Estill, T. Han, R. Diaz-Arrastia, E. W. Brunskill, S. S. Potter, and S. L. McKnight
Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors
PNAS,
September 14, 2004;
101(37):
13648 - 13653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D'Arcangelo
Response to Comment on "Reelin Promotes Peripheral Synapse Elimination and Maturation"
Science,
March 26, 2004;
303(5666):
1977c - 1977c.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Krathwohl and J. L. Kaiser
Chemokines Promote Quiescence and Survival of Human Neural Progenitor Cells
Stem Cells,
January 1, 2004;
22(1):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chih and P. Scheiffele
Is Reelin the Answer to Synapse Elimination at the Neuromuscular Junction?
Sci. Signal.,
October 21, 2003;
2003(205):
pe45 - pe45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Molinari, V. Meskanaite, A. Munnich, P. Sonderegger, and L. Colleaux
Extracellular proteases and their inhibitors ingenetic diseases of the central nervous system
Hum. Mol. Genet.,
October 15, 2003;
12(90002):
R195 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Quattrocchi, C. Huang, S. Niu, M. Sheldon, D. Benhayon, J. Cartwright Jr., D. R. Mosier, F. Keller, and G. D'Arcangelo
Reelin Promotes Peripheral Synapse Elimination and Maturation
Science,
August 1, 2003;
301(5633):
649 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dong, H. Caruncho, W. S. Liu, N. R. Smalheiser, D. R. Grayson, E. Costa, and A. Guidotti
A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes
PNAS,
April 29, 2003;
100(9):
5479 - 5484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Rubin, R. P. Tucker, M. Brown-Luedi, D. Martin, and R. Chiquet-Ehrismann
Teneurin 2 is expressed by the neurons of the thalamofugal visual system in situ and promotes homophilic cell-cell adhesion in vitro
Development,
March 12, 2003;
129(20):
4697 - 4705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Schmid and E.S. Anton
Role of Integrins in the Development of the Cerebral Cortex
Cereb Cortex,
March 1, 2003;
13(3):
219 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Martinez-Cerdeno, M. J. Galazo, C. Cavada, and F. Clasca
Reelin Immunoreactivity in the Adult Primate Brain: Intracellular Localization in Projecting and Local Circuit Neurons of the Cerebral Cortex, Hippocampus and Subcortical Regions
Cereb Cortex,
December 1, 2002;
12(12):
1298 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. X. Gomis-Ruth, A. Bayes, G. Sotiropoulou, G. Pampalakis, T. Tsetsenis, V. Villegas, F. X. Aviles, and M. Coll
The Structure of Human Prokallikrein 6 Reveals a Novel Activation Mechanism for the Kallikrein Family
J. Biol. Chem.,
July 19, 2002;
277(30):
27273 - 27281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|